Articles that mention Biogen -BoardProspects

Biogen

0 Comments Leave a Comment

1-15 of 20 1 2 »
1. Mentioned In 20 Articles
2. Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
  
  Explore Yahoo Finance Apr 1 2022 BoardMoves
  
  ...he served as director of molecular biology and director of market and business development at Biogen, Inc. At Biogen, he invented and led the discovery and development of bivalirudin for injection. Dr. Maraganore has Ph....
  Read Full Article
  
  Comment
  
  Mentions: National Association of Corporate Directors acquisition Japan
3. Biogen Shareholders Sues Board of Directors Over Fiduciary Duty Misconduct
  
  Explore Home - Law Street Media Feb 12 2022 BoardNews
  
  ...ainst the Biogen Board of Directors, in a derivative complaint on behalf of Biogen, Inc. They allege that the Biogen board breached their fiduciary duties, violated federal securities laws, and engaged in other misconduc...
  Read Full Article
  
  Comment
  
  Mentions: Fiduciary Duties Shareholder Lawsuit Biogen
4. Biogen Announces Nancy Leaming and Brian Posner to Retire from Board of Directors
  
  Explore Yahoo! Finance Jan 31 2022 BoardMoves
  
  ...Biogen Inc. (Nasdaq: BIIB) today announced that Nancy Leaming and Brian Posner will retire from Biogens Board of Directors, effective at the time of the Companys 2022 annual meeting of stockholders... ...
  Read Full Article
  
  Comment
  
  Mentions: Annual Meeting Nasdaq retire
5. Coya Therapeutics™ Announces the Appointment of Anabella Villalobos, Ph.D. to its Board of Directors
  
  Explore GlobeNewswire May 25 2021 BoardMoves
  
  ... announced that it has appointed Anabella Villalobos Ph.D., Head of Biotherapeutics and Medicinal Sciences of Biogen, to the Companys Board of Directors, effective immediately... ...
  Read Full Article
  
  Comment
  
  Mentions: Biogen Board Anabella Villalobos
6. Biogen Announces Two New Nominees for Election to Board of Directors
  
  Explore GlobeNewswire Apr 10 2021 BoardMoves
  
  ...CAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the nomination of Maria C. Freire, Ph.D. and William D. Jones to stand for election to the companys board of direc...
  Read Full Article
  
  Comment
  
  Mentions: Management Annual Meeting Nasdaq
7. Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors
  
  Explore GlobeNewswire Aug 4 2020 BoardMoves
  
  ...ties on more than 45 commercial products, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko ...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Investor Relations Investment
8. Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors
  
  Explore businesswire.com Jul 23 2020 BoardMoves
  
  ... 2019. Prior to that, Mr. Clancy was Executive Vice President and Chief Financial Officer of Biogen. While at Biogen, he successfully led the financial strategy of the company over a ten-year period of growth. Mr. Clancy...
  Read Full Article
  
  Comment
  
  Mentions: Management Alexion Pharmaceuticals Selective
9. NeoGenomics (NEO) Adds Rachel A. Stahler and Michael A. Kelly to Board
  
  Explore StreetInsider.com Jul 20 2020 BoardMoves
  
  ... Services and Vice President & CFO, International Commercial Operations. Mr. Kelly has also held positions at Biogen, Tanox and Monsanto Life Sciences. Mr. Kelly serves on the Council of Advisors and was the former audit...
  Read Full Article
  
  Comment
  
  Mentions: Human Resources Leadership Independent Director
10. After a Bitter Fight, Activist Boots Progenics Directors—and Eyes a CEO Swap Next
  
  Explore Pharma News Nov 11 2019 BoardNews
  
  ... on Genzyme's board ahead of that sale to Sanofi and worked with activist Carl Icahn during his challenges to Biogen leadership. However, Progenics' shareholders opted to go even further than ISS recommended, also choosi...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi ISS acquisition
11. Finch Therapeutics Announces Appointment of Dr. Jo Viney and Domenic Ferrante to its Board of ...
  
  Explore businesswire.com Sep 25 2019 BoardMoves
  
  ...ating autoimmune and inflammatory diseases. Prior to Pandion, she worked at Immunex, Amgen, and most recently Biogen, where she was Senior Vice President of the Drug Discovery Organization. Throughout her career, Jo has ...
  Read Full Article
  
  Comment
  
  Mentions: Investment Harvard MBA
12. Bristol-Myers Squibb Board Announces Election of Three New Directors
  
  Explore businesswire.com Sep 11 2019 BoardMoves
  
  ...l December 2014. Prior to Cubist, he was Vice President, Sales and Marketing at Biogen, Inc. Prior to joining Biogen, Mr. Bonney spent eleven years at Zeneca Pharmaceuticals, in a range of commercial, operating and strat...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Advisory Boards Management
13. Aleta Biotherapeutics Announces Appointments to Board of Directors
  
  Explore businesswire.com Sep 5 2019 BoardMoves
  
  ... Corporation, and Therion Biologics Corporation. Prior to Therion, Mr. Leuchtenberger was a senior officer at Biogen Inc., where he led the late-stage development of its flagship product Avonex and its commercialization ...
  Read Full Article
  
  Comment
  
  Mentions: Management Governance Committee IPO
14. Prothena Announces Appointment of Paula K. Cobb to its Board of Directors
  
  Explore Google Jul 1 2019 BoardMoves
  
  ...Until its acquisition by Biogen, Ms. Cobb served on the board of directors of Nightstar Therapeutics plc, a clinical-stage gene therapy company. Prior to... ...
  Read Full Article
  
  Comment
  
  Mentions: acquisition Biogen Paula Cobb
15. Biogen Announces Three New Nominees for Election to Board of Directors
  
  Explore Yahoo! Finance Apr 29 2019 BoardMoves
  
  ...CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) --Biogen(BIIB) today announced the nomination of John R. Chiminski, William A. Hawkins and Jesus B. Mantas to stand for election to the companys board of direct...
  Read Full Article
  
  Comment
  
  Mentions: Annual Meeting Biogen John Chiminski
16. Now that Ironwood's Spinning off R&D, Activist Alex Denner is Easing Up
  
  Explore Pharma News Jun 1 2018 BoardNews
  
  ...” Sarissa said. In particular, it wants to see two completely separate companies with no cross-ownership—a la Biogen and its 2017 hemophilia spinoff Bioverativ, which Sarissa also just so happened to advocate for. RELATE...
  Read Full Article
  
  Comment
  
  Mentions: Sarissa Allergan AMP
17. 1-15 of 20 1 2 »